103 related articles for article (PubMed ID: 3962865)
1. Comparison of exercise and ajmaline tests with electrophysiologic study in the Wolff-Parkinson-White syndrome.
Eshchar Y; Belhassen B; Laniado S
Am J Cardiol; 1986 Apr; 57(10):782-6. PubMed ID: 3962865
[TBL] [Abstract][Full Text] [Related]
2. Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome.
Brugada P; Dassen WR; Braat S; Gorgels AP; Wellens HJ
Am J Cardiol; 1983 Jul; 52(1):70-2. PubMed ID: 6858931
[TBL] [Abstract][Full Text] [Related]
3. [An electrophysiologic and electropharmacological study of functional properties of the bundle of Kent in Wolff-Parkinson-White syndrome].
Costantini M; Chimienti M; Zardini M; Klersy C; Guasti L; Salerno JA
Cardiologia; 1989 Apr; 34(4):365-74. PubMed ID: 2758442
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of noninvasive tests for identifying patients with preexcitation syndrome at risk of rapid ventricular response.
Critelli G; Gallagher JJ; Perticone F; Coltorti F; Monda V; Condorelli M
Am Heart J; 1984 Oct; 108(4 Pt 1):905-9. PubMed ID: 6486001
[TBL] [Abstract][Full Text] [Related]
5. Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway.
Wellens HJ; Braat S; Brugada P; Gorgels AP; Bär FW
Am J Cardiol; 1982 Nov; 50(5):1087-9. PubMed ID: 7137035
[TBL] [Abstract][Full Text] [Related]
6. Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathway.
Wellens HJ; Bär FW; Gorgels AP; Vanagt EJ
Am J Cardiol; 1980 Jan; 45(1):130-3. PubMed ID: 7350760
[TBL] [Abstract][Full Text] [Related]
7. [Effect of heart rate on the refractory period of the accessory atrioventricular pathway in Wolff-Parkinson-White syndrome].
Fromer M; Gloor H; Kappenberger L
Schweiz Med Wochenschr; 1985 Nov; 115(44):1545-51. PubMed ID: 4081683
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of exercise and isoproterenol on the antegrade refractory period of the accessory pathway in patients with Wolff-Parkinson-White syndrome.
Yamabe H; Okumura K; Yasue H
Jpn Circ J; 1994 Jan; 58(1):22-8. PubMed ID: 8139088
[TBL] [Abstract][Full Text] [Related]
9. [Electrophysiological effects of chloroacetyl ajmaline in Wolff-Parkinson-White syndrome].
Touboul P; Gressard A; Atallah G; Chatelain MT; Delahaye JP
Arch Mal Coeur Vaiss; 1978 Jul; 71(7):808-15. PubMed ID: 102281
[TBL] [Abstract][Full Text] [Related]
10. Utility of Exercise Testing and Adenosine Response for Risk Assessment in Children with Wolff-Parkinson-White Syndrome.
Ergul Y; Ozturk E; Ozyilmaz I; Unsal S; Carus H; Tola HT; Tanidir IC; Guzeltas A
Congenit Heart Dis; 2015; 10(6):542-51. PubMed ID: 26010236
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of dual accessory pathways by ajmaline test.
Belhassen B; Bar-David S; Laniado S
Cardiology; 1989; 76(1):53-7. PubMed ID: 2706645
[TBL] [Abstract][Full Text] [Related]
12. Relationship between age and anterograde refractoriness of the accessory pathway in Wolff-Parkinson-White patients.
Michelucci A; Padeletti L; Mezzani A; Giovannini T; Miceli M; Cupelli V; Musante R
Cardiology; 1989; 76(4):270-3. PubMed ID: 2805013
[TBL] [Abstract][Full Text] [Related]
13. Two false-negative responses to the ajmaline test in the Wolff-Parkinson-White syndrome.
Cavalli A; Maggioni A; Tusa M; Volpi A
Pacing Clin Electrophysiol; 1985 Nov; 8(6):832-7. PubMed ID: 2415936
[TBL] [Abstract][Full Text] [Related]
14. [Wolff-Parkinson-White syndrome. Value of transesophageal atrial stimulation coupled with exercise test for the study of anterograde conduction in the accessory pathway].
Cebron JP; Le Marec H; Victor J; Chevallier JC; Borgat C; Godin JF
Arch Mal Coeur Vaiss; 1989 Feb; 82(2):159-66. PubMed ID: 2500076
[TBL] [Abstract][Full Text] [Related]
15. A modified ajmaline test for prediction of the effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome.
Chimienti M; Moizi M; Klersy C; Guasti L; Salerno JA
Am J Cardiol; 1987 Jan; 59(1):164-5. PubMed ID: 3812229
[No Abstract] [Full Text] [Related]
16. Intermittent versus Persistent Wolff-Parkinson-White Syndrome in Children: Electrophysiologic Properties and Clinical Outcomes.
Kiger ME; McCanta AC; Tong S; Schaffer M; Runciman M; Collins KK
Pacing Clin Electrophysiol; 2016 Jan; 39(1):14-20. PubMed ID: 26256551
[TBL] [Abstract][Full Text] [Related]
17. Effect of adenosine triphosphate on the accessory pathways.
Perrot B; Clozel JP; Faivre G
Eur Heart J; 1984 May; 5(5):382-93. PubMed ID: 6734648
[TBL] [Abstract][Full Text] [Related]
18. [The clinical significance of the ajmaline test in the noninvasive diagnosis of the Wolff-Parkinson-White syndrome].
Neuzner J; Pitschner HF; Jakob H; Schlepper M
Dtsch Med Wochenschr; 1994 Jul; 119(28-29):985-9. PubMed ID: 8039452
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern.
Kubuš P; Vít P; Gebauer RA; Materna O; Janoušek J
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):218-23. PubMed ID: 24488978
[TBL] [Abstract][Full Text] [Related]
20. Relation of the utility of exercise testing for risk assessment in pediatric patients with ventricular preexcitation to pathway location.
Spar DS; Silver ES; Hordof AJ; Liberman L
Am J Cardiol; 2012 Apr; 109(7):1011-4. PubMed ID: 22221954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
